ARS Treatment Centers, a national leader in Office-Based Opioid Treatment (OBOT), announced today that it has opened a new clinic in Paterson, New Jersey.
- The Paterson clinic is located at 66 Hamilton St., Suite 204, Paterson, NJ 07505.
All ARS clinics see patients by appointment only. Patients seeking treatment services at any ARS facility should call (866)-866-9277 to schedule an appointment. ARS accepts Medicaid and most major commercial insurance plans.
“On behalf of the entire team at ARS, I’m excited to announce another life-saving treatment facility in the state of New Jersey. As we continue to expand throughout the state, we are pleased to increase access to patient-centric, local resources to combat the opioid epidemic,” said Dr. Kevin Moore, Director of Integrative Medicine at ARS Treatment Centers. “With the opening of our Paterson clinic, we further our commitment to the citizens of New Jersey. We now have built a critical mass of operations in the state, with additional plans to invest in these critical community resources.”
There are several job openings across the state of New Jersey for qualified medical professionals. Interested applicants can review open positions and apply HERE.
To learn more about ARS Treatment Centers resources, visit www.arstreatmentcenters.com
About ARS Treatment Centers
ARS Treatment Centers is a subsidiary of Crossroad Treatment Centers. Headquartered in Greenville, SC, together the two brands operate more than 80 addiction treatment facilities in 10 states. With proven, individualized treatment plans (medication, counseling, and toxicology services) the family of dedicated doctors, nurse practitioners, counselors, and professionals at ARS and Crossroads are able to provide the highest quality of professional care to over 20,000 patients each month. Understanding that the opioid crisis is an epidemic that demands aggressive implementation of critical resources to increase patient access to treatment, ARS has committed to opening more than 20 new treatment facilities in the third and fourth quarter of 2019.
View source version on businesswire.com: https://www.businesswire.com/news/home/20191029005707/en/
Source: ARS Treatment Centers
View this news release online at:
http://www.businesswire.com/news/home/20191029005707/en
